Sichuan University: Carcinoma, Non-Small-Cell Lung trials
The registry lists 14 Carcinoma, Non-Small-Cell Lung studies with Sichuan University as lead sponsor. 8 are open to participants now and 3 have results posted.
Phase 1 6Phase 2 7Phase 4 1No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLCRecruitingNCT07748325Phase 2
- NAD+ Supplement（NMN）With Radioimmunotherapy in Advanced NSCLCNot yet recruitingNCT06966583Phase 1
- A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLCRecruitingNCT06951464Phase 2
- Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung CancerRecruitingNCT06877299Phase 2
- A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLCRecruitingNCT06769295Phase 2
- Sunvozertinib Combined With Chemotherapy for EGFRm After EGFR-TKI Treatment Failure：Phase I/IIRecruitingNCT06195189Phase 1/2
- Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung CancerNot yet recruitingNCT05900921Phase 2
- A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung CancerNot yet recruitingNCT05186506Phase 2
- Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung CancerCompletedNCT04012619Phase 1Results posted
- Safety and Tolerability Evaluation of Sintilimab in Combination With Radiation in Stage IV NSCLC PatientsCompletedNCT03812549Phase 1Results posted
- PD-1 Knockout Engineered T Cells for Metastatic Non-small Cell Lung CancerCompletedNCT02793856Phase 1Results posted
- A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC PatientsStatus unknownNCT03373955
- Personalized DC Vaccine for Lung CancerStatus unknownNCT02956551Phase 1
- Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLCTerminatedNCT02299765Phase 4